Real-time software company Vection Technologies Ltd (ASX:VR1) has signed a first public hospital to trial its Augmented Reality (AR) healthcare solutions.
The initial trial agreement has been reached with AORN S.G. Moscati Hospital and Luiss Libera Università Internazionale degli Studi Sociali Guido Carli.
This trial will be critical for the introduction of AR solutions in the Italian Model for Risk Management in Healthcare promoted by LUISS Business School, a national model that operators must adopt to manage risk in Healthcare.
The trial will focus on integrating Vection Technologies’ AR Healthcare solutions, based on FrameS’ technology infrastructure, within the Moscati hospital, focussing on:
- Real-time integration of data fields from endoscopic equipment in the surgeon’s field of view, through AR wearable devices. This solution delivers a more precise and safe AR-based navigation system compared to conventional endoscopic procedures.
- Real-time integration of electronic medical record system (EMRS) with AR, enabling healthcare professionals to access medical information through AR wearable devices.
Gianmarco Biagi, Managing Director of Vection Technologies,said that with ~1,000 accredited hospitals, of which ~52% public, Italy represents the ideal test market for the company to introduce its real-time healthcare focussed solutions.
The commitment by this first hospital represents a strong advancement of the company’s strategy across healthcare, aligned with the stated six-months objectives.
This initial trial represents the culmination of a lengthy regulatory process with key public stakeholders enabling Vection Technologies to affirm itself at the forefront of the digital healthcare transformation, introducing augmented reality as a new standard in healthcare risk management,” Mr Biagi said.
This agreement represents a key commercial milestone setting the foundations for long-term growth, providing for a strong opportunity for recurring revenue growth during the second half of FY21 and into FY22.”
